Updated on 11 August 2026
0xmd Medical AI
Medical & Healthcare AI at 0xmd Inc.
China (Hong Kong)
About
We provide 24-hour online professional medical consultation and health management to our users or patients, and also clinical training and workflow management to our institutional clients. Our products developed include our Website & Mobile App, our Education Software co-owned and patented by the University of Hong Kong (HKU), Telemedicine platform, Hospital Mainframe AI, a simplified API, and a number of customised AI solutions designed for governmental departments and agencies in different countries or regions.
We are expanding our footprint in Brazil as our first stop in Latin America, and in the US too. We are looking for local partners preferably doctors/doctors' organisations, hospitals or medical groups, and insurance companies in Brazil and US. We are also raising funds to support our growth in these countries.
Project Location
- China (Hong Kong)
Project Website
https://www.0xmd.com
Project Format
- Private Project
Go Global Project
- Yes
ESG (Environmental, Social, and Governance)
- No
Project Stage
- Investment / Financing Discussion
Main Project Sector
- Technology
Technology
- Health Technology
- Medical Technology
Total Project Value
- 2,500,001 to 5,000,000 USD
Investment Capital Required
- 1,000,001 to 2,500,000 USD
Interested Format of Cooperation
- Direct Equity Investment
- Joint Venture
- Open for Negotiation
Preferred Financing Model
- Equity
Type(s) of Last Financing Round of the project (if Applicable)
- Equity (private)
Total amount raised (USD)
449,000
Main Service(s) Required
- Information Technology Services
Financial Services
- Private Equity & Venture Capital
Attached files
Organisation
China (Hong Kong)
Similar opportunities
Project
Point-of-care Early Cancer Breath Testing
- No
- Yes
- Debt
- Equity
- Technology
- Private Project
- Health Technology
- Convertible Loan
- Equity (private)
- Medical Technology
- Financial Services
- Open for negotiation
- Open for Negotiation
- Minority Shareholdings
- Direct Equity Investment
- Institutional Investment
- 2,500,001 to 5,000,000 USD
- Public / Alternative Financing
- Private Equity & Venture Capital
- Investment / Financing Discussion
Grover Cheung
Founder & CEO at Qi Diagnostics Limited
China (Hong Kong)
Project
- No
- Yes
- Equity
- Technology
- Private Project
- Private Banking
- Health Technology
- Equity (private)
- Medical Technology
- Financial Services
- Investment Banking
- Mergers & Acquisition
- Direct Equity Investment
- 2,500,001 to 5,000,000 USD
- 7,500,001 to 10,000,000 USD
- Private Equity & Venture Capital
- Investment / Financing Discussion
Avi Lior
CEO at Therapnea Labs PLC
Cyprus
Project
Cross‑border Digital Medical Marketplace Project — Doctor‑Mall
- Yes
- Yes
- Equity
- E-payment
- Technology
- IP Related
- IT Security
- Consultancy
- Tax Advisory
- Joint Venture
- Bootstrapping
- IT Consulting
- Cloud Solution
- Legal Advisory
- Public Project
- Mobile Solutions
- Health Technology
- Big Data Solution
- Digital Marketing
- Financial Services
- Corporate Services
- Financial Advisory
- Legal Due Diligence
- Open for negotiation
- Open for Negotiation
- Professional Services
- Minority Shareholdings
- Requisition of Service
- Financial Due Diligence
- Direct Equity Investment
- Institutional Investment
- 1,000,001 to 2,500,000 USD
- 1,000,001 to 2,500,000 USD
- Feasibility Study Completed
- Information Technology Services
- Market Entry Strategic Analysis
- Private Equity & Venture Capital
- Risk Management (Financial Services)
Fairy LI
CEO at WELLNEST HEALTHCARE TECHNOLOGY CO., LIMITED
China (Hong Kong)